Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
about
Cannabis Use during Adolescent Development: Susceptibility to Psychiatric IllnessTargeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugsDevelopment of highly sensitive fluorescent assays for fatty acid amide hydrolaseEndocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesityBrain monoglyceride lipase participating in endocannabinoid inactivationSelective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effectsFatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injuryNovel bioactive metabolites of dipyrone (metamizol)The endocannabinoid system as a target for the treatment of cannabis dependenceThe endocannabinoid system as an emerging target of pharmacotherapyA comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerolThe elmiric acids: biologically active anandamide analogsEndocannabinoid signaling controls pyramidal cell specification and long-range axon patterningEndocannabinoids in the retina: from marijuana to neuroprotectionOrganophosphate-sensitive lipases modulate brain lysophospholipids, ether lipids and endocannabinoidsAnandamide and vanilloid TRPV1 receptorsInactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoidsMechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymesEvidence against the presence of an anandamide transporterFetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids SignalingParsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNSChemical probes of endocannabinoid metabolismCannabinoids as therapeutic agents in cancer: current status and future implicationsTherapeutic potential of monoacylglycerol lipase inhibitorsThe pharmacological landscape and therapeutic potential of serine hydrolasesGPCRs in stem cell functionTRPV1 in brain is involved in acetaminophen-induced antinociceptionEndocannabinoids control platelet activation and limit aggregate formation under flowΔ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in miceThe endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathwaysStructure-guided inhibitor design for human FAAH by interspecies active site conversionDiscovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory PainInitial insight into the function of the lysosomal 66.3 kDa protein from mouse by means of X-ray crystallographyCrystal Structure of Fatty Acid Amide Hydrolase Bound to the Carbamate Inhibitor URB597: Discovery of a Deacylating Water Molecule and Insight into Enzyme InactivationReversible Competitive α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Containing Additional Conformational Constraints in the Acyl Side Chain: Orally Active, Long-Acting AnalgesicsDiscovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH)A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide HydrolaseRational Design of Fatty Acid Amide Hydrolase Inhibitors That Act by Covalently Bonding to Two Active Site ResiduesCrystallographic study of FABP5 as an intracellular endocannabinoid transporterInteraction between Cannabinoid System and Toll-Like Receptors Controls Inflammation
P2860
Q21090462-755185FB-3823-4CE8-A303-2552CCBD8C8BQ21090833-2C8BF948-9250-44C6-9DFA-EB02748B0A26Q23913685-493DC686-9761-4F36-9AF5-9BBF8BDCB274Q24523292-2EDB0712-B905-419C-8A5E-EAA8D0B3B5B6Q24533828-22F407BC-1C78-41E8-9945-E4E4C1A97840Q24569799-539EE006-0483-4815-A804-E579E10822E2Q24595633-F49CCE92-4713-46D9-BE8C-F0F3E808CDE6Q24616603-0E5D52B2-543E-4720-A3B5-AAFE7B63BF0EQ24648135-06D96F06-A289-4ED0-87CF-ADDCC82ABEE5Q24648473-48A7F764-97B1-4EBF-ACBA-13C69EF4E82FQ24649418-A5A1DA7B-18C1-42F9-BAE0-5535D7BC7FAFQ24650559-E6E95374-274A-4D64-A00A-5B37AB36D9A9Q24650912-312BA39A-76A2-463A-A917-315F70E435E6Q24656049-754B83E0-0D2A-48A3-BF2A-F968C5886CD3Q24658124-53E01962-C2D8-45F8-8254-623D6FE1F75FQ24672354-B00BE9F5-822F-4ECD-AB51-E9A2B219423AQ24680497-7C068EAC-4327-406B-9303-DB898159F516Q24680869-073631B7-791E-44EC-AEDC-2C9CCFC3CBC6Q24683153-0431C6EE-FCEB-4801-A2F6-C2225E2BA5AAQ26777055-F19509FB-47E4-4D5D-B6B7-F5977F0F57BCQ26853436-FFDC4BBF-FFC5-48F9-A74A-FB2F73389388Q26863202-554F0FA3-4C69-4725-B12D-E8CFA76A98EDQ26866298-E5E7774A-0569-4E0E-ABB4-8A31271B2ECDQ26991513-C4269B52-82CD-4C56-B850-BDF10D321102Q26995817-D36E2733-B9BC-4F47-9FF7-1567FFC3E770Q27003270-31BAACF2-61DD-4C79-9DCD-8323DABA9E1BQ27320173-57783C6A-D7BB-40BB-9CE6-9E8A18A32749Q27345221-1D39FE1F-CF84-49B6-B6C6-66434E3280BDQ27345385-7F047A8D-26E4-42C2-8C56-9C71F9A84324Q27496303-099B5A64-8732-4AE5-897C-C88FE84DCC18Q27651822-AC2F1D5B-BCA4-4387-B6FE-16AF01DC13DFQ27655121-56C44662-6074-4F97-A493-E0B5D1FAD489Q27657154-D1564C65-3BEF-4041-BFC0-56C2BE86EA32Q27661834-606C7848-90EB-458B-AD89-A8549D969B60Q27667312-EEEDCB5C-6CFD-46CF-9F25-8CBF13E936D6Q27667550-E6B7467A-CB15-41F4-B23C-9D4CC298473BQ27675504-343D81DF-08A5-4602-B1D6-003A5C26BB6CQ27677344-2DC5D9CC-4833-4BCA-A2D7-7BDA162E0CE4Q27681752-BBA8EF17-6119-49E9-B6C4-FF3510D1C0ADQ28066215-BD12BFAB-ACB4-4FA3-A6ED-047ADB917F0A
P2860
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Supersensitivity to anandamide ...... ing fatty acid amide hydrolase
@ast
Supersensitivity to anandamide ...... ing fatty acid amide hydrolase
@en
Supersensitivity to anandamide ...... ing fatty acid amide hydrolase
@nl
type
label
Supersensitivity to anandamide ...... ing fatty acid amide hydrolase
@ast
Supersensitivity to anandamide ...... ing fatty acid amide hydrolase
@en
Supersensitivity to anandamide ...... ing fatty acid amide hydrolase
@nl
prefLabel
Supersensitivity to anandamide ...... ing fatty acid amide hydrolase
@ast
Supersensitivity to anandamide ...... ing fatty acid amide hydrolase
@en
Supersensitivity to anandamide ...... ing fatty acid amide hydrolase
@nl
P2093
P2860
P921
P3181
P356
P1476
Supersensitivity to anandamide ...... ing fatty acid amide hydrolase
@en
P2093
A H Lichtman
B F Cravatt
K Demarest
M H Bracey
M P Patricelli
P2860
P304
P3181
P356
10.1073/PNAS.161191698
P407
P577
2001-07-31T00:00:00Z